Lucid Diagnostics Inc. (LUCD) Social Stream
LUCID DIAGNOSTICS INC (LUCD) Price Targets From Analysts
The tables below show price targets and recommendations from analysts covering LUCID DIAGNOSTICS INC.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-11-08 | 4 | $21 | $14 | $17.5 | $1.33 | 1215.79% |
| 2021-12-15 | 4 | $21 | $13 | $16.5 | $1.33 | 1140.6% |
| 2021-12-27 | 5 | $21 | $13 | $16.4 | $1.33 | 1133.08% |
| 2022-02-04 | 5 | $21.001 | $13 | $16.4 | $1.33 | 1133.08% |
| 2022-03-30 | 5 | $18 | $12 | $14.6 | $1.33 | 997.74% |
| 2022-04-05 | 5 | $16 | $6 | $10.6 | $1.33 | 696.99% |
| 2022-05-12 | 5 | $16 | $6 | $10 | $1.33 | 651.88% |
| 2022-08-16 | 3 | $16 | $4.25 | $8.65 | $1.33 | 550.38% |
| 2022-11-15 | 4 | $16 | $3.1 | $8.32 | $1.33 | 525.56% |
| 2022-11-18 | 3 | $8.5 | $3.1 | $5.775 | $1.33 | 334.21% |
| 2023-03-15 | 3 | $8 | $2.6 | $4.65 | $1.33 | 249.62% |
| 2023-05-17 | 3 | $4 | $2.6 | $3.366 | $1.33 | 153.08% |
| 2023-08-17 | 3 | $4 | $2.8 | $3.433 | $1.33 | 158.12% |
| 2023-11-15 | 3 | $3.8 | $2.5 | $3.266 | $1.33 | 145.56% |
The Trend in the Analyst Price Target
LUCD's average price target has moved down $1.5 over the prior 35 weeks.
LUCD reports an average of 155.54% for its upside potential over the past 43 weeks.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2023-01-20 | 3 | 8.0 | 3.1 | 4.775 | 1.32 | 261.74% |
| 2023-03-15 | 3 | 8.0 | 2.6 | 4.650 | 1.77 | 162.71% |
| 2023-03-15 | 3 | 4.5 | 2.6 | 3.533 | 1.77 | 99.6% |
| 2023-08-17 | 3 | 4.0 | 2.8 | 3.433 | 1.40 | 145.21% |
| 2023-11-15 | 3 | 3.8 | 2.5 | 3.266 | 1.33 | 145.56% |
LUCD Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1.33 | 2 | 1 | 0 | 0 | 0 | 3 |
The Trend in the Broker Recommendations
LUCD's average broker recommendation rating worsened by 0.08 over the prior 24 months.
The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.
- LUCID DIAGNOSTICS INC's upside potential (average analyst target price relative to current price) is greater than 2279.24% of all US stocks.
- In terms of how LUCID DIAGNOSTICS INC fares relative to all US stocks, note that its average analyst price target is higher than 256.13% of that group.
- In the context of all US stocks, LUCID DIAGNOSTICS INC's number of analysts covering the stock is higher than 351.05% of them.
- In the context of stocks in the micro market cap category, LUCID DIAGNOSTICS INC's variance in analysts' estimates is lower than -1835.29% of them.
In terms of price targets and recommendations offered by analysts, the stocks in the Medical Equipment industry with the ratings most similar to LUCID DIAGNOSTICS INC are UTRS, BJDX, and BEAT.
View All Top Stocks by Price Target
Make investment decisions regarding LUCD using the data that counts. Try POWR Ratings for free.